Title: | A Pharmaceutical Composition Useful for the Treatment of Benign Prostate Hyperplasia |
Area: | Medical Sciences, Pharmaceutical Sciences |
Focus Area: | Treatment of Benign Prostate Hyperplasia |
Patent: | GB2443588, CN101267859, EP1933945 |
Social Benefits: | Can be made available in wide ranging formulations pharmaceutical composition is in an oral, intravenous, intramuscular, or subcutaneous formulation for using various delivery routes High specificity of the extract and mahanine for inducing apoptosis in prostate cancer cells No indication of any toxicity, other cells such as hepatocytes, cardiomyocytes, and skeletal muscle are not killed by the pharmaceutical composition of this invention The pharmaceutically active fraction can be extracted from any plant parts be it leaves, stems, fruits, or any other part of the Murraya koenigii. Simplified method of bioactive extraction and a simplified fast and inexpensive process for the preparation of fraction mahanine possessing significantly high biological activities relevant to treatment, relief and remedy of prostate cancer Pharmaceutical composition which is highly compatible for human consumption |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (IICB), West Bengal |
Technology Readiness Index: | Market Launch |
Email: | director@iicb.res.in |
| Website Link : | http://www.iicb.res.in |
| Source (more info) : | https://t.ly/l_sb |